M7: A novel in vitro CDK1 inhibitor suppressing colorectal cancer cell proliferation, migration and promoting apoptosis
Authors:
- Lihong YangLYLihong Yang
- Yipan ZhuYZYipan Zhu
- Xinyu DingXDXinyu Ding
- Jing SunJSJing Sun
- Xinyu CaoXCXinyu Cao
- Zhisong ZhangZZZhisong Zhang
- Luyuan LiLLLuyuan Li
- Jianping LinJLJianping Lin
Open Access
- 13 May 2025
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry Reports
- Vol. 14
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China (82073064)
- National Natural Science Foundation of China (81874167)
- National Key Research and Development Program of China (2017YFC1104400)
This publication has 47 references indexed in Scilit:
- Anticancer Attributes and Multifaceted Pharmacological Implications of Laetrile and AmygdalinCell Biology International, 2025
- Identification of a Novel Selective CDK9 Inhibitor for the Treatment of CRC: Design, Synthesis, and Biological Activity EvaluationJournal of Medicinal Chemistry, 2024
- The effects of thymoquinone on pancreatic cancer: Evidence from preclinical studiesBiomedicine & Pharmacotherapy, 2022
- Colorectal cancerThe Lancet, 2019
- Research Techniques Made Simple: Analysis of Collective Cell Migration Using the Wound Healing AssayJournal of Investigative Dermatology, 2017
- The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence AnalysesCurrent Protocols in Bioinformatics, 2016
- 1001 Ways to run AutoDock Vina for virtual screeningJournal of Computer-Aided Molecular Design, 2016
- Overtreatment of Young Adults With Colon CancerJAMA Surgery, 2015
- Ligand docking and binding site analysis with PyMOL and Autodock/VinaJournal of Computer-Aided Molecular Design, 2010
- Cdk1 is sufficient to drive the mammalian cell cycleNature, 2007